Program

5 November 2021

Time zone: GMT +1, CET (Central European Time)

8:30 – 8:40 Opening: Dr. Elisabeth Arrojo

8:40 – 11:05 Session I

  • 8:40 – 9:00 Its time for prime time for oncologic hyperthermia/thermotherapy, Prof. Stephan Bodis
  • 9:00 – 9:05 discussion
  • 9:25 – 9:45 Hyperthermia: a potential game changer in the management of cancers in low-middle-income group countries, Prof. Niloy Ranjan Datta
  • 9:45 – 9:50 discussion
  • 9:50 – 10:10 Use of the preclinical LabEHY-200 System to compare modulated and unmodulated electromagnetic fields at 13.56 MHz, Dr. Pirus Ghadjar
  • 10:10 – 10:15 discussion
  • 10:15 – 10:35 Update on mEHT Glio phase III trial. First results and comments, Dr. Elisabeth Arrojo
  • 10:35 – 10:40 discussion
  • 10:40 – 11:00 Enhancing surface electromagnetic intensity by covering a silver fabric for superficial located tumor treatment during oncothermia, Prof. Kwan-Hwa Chi
  • 11:00 – 11:05 discussion

11:05 – 12:05 Break with poster presentations

  • 11:05 – 11:10 The effect of combined oncotherapy (modulated electro-hyperthermia + gemcitabine) on chemoresistant and chemosensitive pancreatic adenocarcinoma cell lines, Gertrud Forika
  • 11:12 – 11:17 In vitro and in vivo Study of the Efficacy and toxicity of combination between Modulated electro Hyperthermia and Thermo-sensitive liposomal Doxorubicin in 4T1 Triple negative breast cancer model, Kenan Aloss
  • 11:19 – 11:24 Non-steroidal anti-inflammatory drugs (NSAID) enhances the mEHT effect on TNBC (4T1,4T07) and melanoma(B16F10) tumor models, Nino Giunashvili
  • 11:26 – 11:31 Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Triple Negative Mouse Breast Cancer, Csaba Schvarz 
  • 11:33 – 11:38 Inhibition of Triple Negative Breast Cancer (TNBC) growth in a mouse model – Enhancement of modulated electro-hyperthermia (mEHT) effects by heat shock factor-1 (HSF1) or progesterone receptor (PgR) inhibition, Pedro Viana
  • 11:40 – 11:45 Modulated electro-hyperthermia induces angiogenic repair in murine triple negative breast cancer model, Mahak Zahra

12:05 – 13:45 Session II

  • 12:05 – 12:25 An overview of Oncothermia as a treatment modality for cervical cancer, Dr. Carrie Minaar
  • 12:25 – 12:30 discussion
  • 12:30 – 12:50 Advanced Pancreatic cancer treated with combo therapy (modulated electro hyperthermia and chemotherapy): a new hope?, Prof. Giammaria Fiorentini
  • 12:50 – 12:55 discussion
  • 12:55 – 13:15 Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients, Prof. Stefan Van Gool
  • 13:15 – 13:20 discussion
  • 13:20 – 13:40 Tumors of the hepato-pancreato-biliary system: can we tame the beast?, Dr. Szasz Marcell
  • 13:40 – 13:45 discussion

13:45 – 13:50 Closing remarks: Dr. Elisabeth Arrojo

 

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close